Literature DB >> 16611646

Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer.

F Bravi1, L Scotti, C Bosetti, R Talamini, E Negri, M Montella, S Franceschi, C La Vecchia.   

Abstract

BACKGROUND: Although prostate cancer is one of the most common male cancers, its aetiology-and particularly the role of comorbidity-remains poorly understood. PATIENTS AND METHODS: Between 1991 and 2002, a case-control study on prostate cancer was conducted in Italy. This included 1294 men under the age of 75 years with incident, histologically confirmed prostate cancer, and 1451 controls, admitted to the same hospitals as cases for a wide spectrum of acute, non-neoplastic diseases. The subjects' self-reported history of selected medical conditions was assessed through a structured and satisfactorily reproducible questionnaire. Multivariate odds ratios (ORs) and 95% confidence intervals (CIs) were obtained after allowance for major potential confounding factors.
RESULTS: A significant direct relation was observed between hypercholesterolaemia and prostate cancer (OR = 1.51, 95% CI 1.23-1.85). This association was stronger (OR = 1.80) in older subjects (age > or =65) than in younger ones (OR = 1.32). A non-significant excess risk of prostate cancer was also observed for gallstones (OR = 1.26, 95% CI 0.93-1.70) and the relation was apparently stronger in patients with lower body mass index (OR = 1.59).
CONCLUSIONS: This study suggests a possible relation between hypercholesterolaemia and prostate cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16611646     DOI: 10.1093/annonc/mdl080

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  22 in total

1.  Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.

Authors:  Mee Young Hong; Susanne Henning; Aune Moro; Navindra P Seeram; Yanjun Zhang; David Heber
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-28

2.  Mechanistic Study of Inhibitory Effects of Atorvastatin and Docetaxel in Combination on Prostate Cancer.

Authors:  Xuan Chen; Yue Liu; Jian Wu; Huarong Huang; Zhiyun Du; Kun Zhang; Daiying Zhou; Kaylyn Hung; Susan Goodin; Xi Zheng
Journal:  Cancer Genomics Proteomics       Date:  2016 Mar-Apr       Impact factor: 4.069

Review 3.  Transit of hormonal and EGF receptor-dependent signals through cholesterol-rich membranes.

Authors:  Michael R Freeman; Bekir Cinar; Jayoung Kim; Nishit K Mukhopadhyay; Dolores Di Vizio; Rosalyn M Adam; Keith R Solomon
Journal:  Steroids       Date:  2006-12-14       Impact factor: 2.668

4.  Serum total and HDL cholesterol and risk of prostate cancer.

Authors:  Alison M Mondul; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Causes Control       Date:  2011-09-14       Impact factor: 2.506

5.  A Class of Semiparametric Mixture Cure Survival Models with Dependent Censoring.

Authors:  Megan Othus; Yi Li; Ram C Tiwari
Journal:  J Am Stat Assoc       Date:  2009-09-01       Impact factor: 5.033

6.  A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer.

Authors:  Gemma Llaverias; Christiane Danilo; Yu Wang; Agnes K Witkiewicz; Kristin Daumer; Michael P Lisanti; Philippe G Frank
Journal:  Am J Pathol       Date:  2010-11-18       Impact factor: 4.307

7.  Ezetimibe is an inhibitor of tumor angiogenesis.

Authors:  Keith R Solomon; Kristine Pelton; Kelly Boucher; Jinsoo Joo; Christopher Tully; David Zurakowski; Carl P Schaffner; Jayoung Kim; Michael R Freeman
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

8.  Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort.

Authors:  Alison M Mondul; Sandra L Clipp; Kathy J Helzlsouer; Elizabeth A Platz
Journal:  Cancer Causes Control       Date:  2009-10-06       Impact factor: 2.506

9.  Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Authors:  Jennifer C Melvin; Lars Holmberg; Sabine Rohrmann; Massimo Loda; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2013-01-20

10.  Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up.

Authors:  Kashif Shafique; Philip McLoone; Khaver Qureshi; Hing Leung; Carole Hart; David S Morrison
Journal:  BMC Cancer       Date:  2012-01-19       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.